Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change?

Saved in:
Bibliographic Details
Published inESMO open Vol. 5; no. 5; p. e000924
Main Authors Lorusso, Domenica, Ray-Coquard, Isabelle, Oaknin, Ana, Banerjee, Susana
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.01.2020
THE AUTHORS. Published by Elsevier Limited on behalf of European Society for Medical Oncology; Originally published by BMJ
Elsevier
Subjects
Betacoronavirus - immunology
Betacoronavirus - pathogenicity
Cancer Care Facilities - organization & administration
Cancer Care Facilities - standards
Cancer Care Facilities - trends
clinical research
Clinical Trials as Topic - organization & administration
Clinical Trials as Topic - standards
Coronavirus Infections - epidemiology
Coronavirus Infections - immunology
Coronavirus Infections - prevention & control
Coronavirus Infections - transmission
COVID-19
Data Accuracy
Europe - epidemiology
Humans
Infection Control - standards
Medical Oncology - organization & administration
Medical Oncology - standards
Medical Oncology - trends
Neoplasms - immunology
Neoplasms - therapy
pandemic telemedicine
Pandemics - prevention & control
Patient Safety
Pneumonia, Viral - epidemiology
Pneumonia, Viral - immunology
Pneumonia, Viral - prevention & control
Pneumonia, Viral - transmission
remote monitoring disruption
Research Design - standards
Research Design - trends
SARS-CoV-2
Telemedicine - organization & administration
Telemedicine - standards
Telemedicine - trends
Europe
clinical research
remote monitoring disruption
pandemic telemedicine
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Scholarly Journals-1
content type line 23
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:2059-7029
2059-7029
DOI:10.1136/esmoopen-2020-000924